In addition, PRKN was markedly downregulated in lung adenocarcinoma (LUAD), colon adenocarcinoma (COAD), thyroid cancer (THCA), and lung squamous cell carcinoma (LUSC), respectively. This evidence concerns the gene PRKN and squamous cell lung carcinoma.